Securities Code: 002370 Securities Abbreviation: Asia-Pacific Pharmaceutical Announcement Number: 2026-026
Zhejiang Asia-Pacific Pharmaceutical Co., Ltd.
Announcement on the Resolutions of the Twelfth Meeting of the Eighth Board of Directors
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, and that there are no false records, misleading statements, or material omissions.
I. Convening of the Board Meeting
-
Time and Method of Notification for the Board Meeting The Eighth Board of Directors' Twelfth Meeting (hereinafter referred to as the "Meeting") of Zhejiang Asia-Pacific Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") was notified to all directors on April 13, 2026, via dedicated person delivery, WeChat, and other methods.
-
Time, Place, and Method of the Board Meeting The Meeting was held on April 23, 2026, in the third-floor conference room of the Company's office building, combining on-site voting and written voting.
-
Attendance at the Board Meeting Of the 9 directors eligible to vote, 9 directors participated in the voting. Directors Yang Zhilong, Han Junlei, and Independent Director Xie Yusheng participated via written voting. Senior management personnel attended the meeting.
-
The Meeting was presided over by Chairman Qiu Zhongxun.
-
The notification, convening, and number of directors participating in the vote for this Meeting comply with relevant laws, regulations, rules, and the Articles of Association.